Age- and sex-related resistance to chronic experimental autoimmune myasthenia gravis (EAMG) in Brown Norway rats

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 189-197

  Hoedemaekers, A ^a   Graus, Y ^a,b   Van Breda Vriesman, P ^a   De Baets, M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Ageing; Autoimmunity; Myasthenia gravis; Resistance; Susceptibility

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; COMPLEMENT; COMPLEMENT MEMBRANE ATTACK COMPLEX;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE RESISTANCE; ETIOLOGY; FEMALE; GENDER; MALE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031014572     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-881.x     Document Type: Article

References (50)

1. Drachman D, Angus C, Adams R et al. Myashenic antibodies crosslink acetylcholine receptors to accelerate degradation. N Engl J Med 1978; 298:1116-22.
2. Loutrari L, Kokla A, Tzartos S. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. Eur J Immunol 1992; 22:2449-52.
3. + flux into TE671 cell line. J Neuroimmunol 1988; 19:141-8.
4. Anwyl R, Appel S, Narahashi T. Myasthenia gravis serum reduces acetylcholine sensitivity in cultured rat myotubes. Nature 1977; 267:262-3.
5. Oosterhuis H. Myasthenia gravis. A survey. Neurol Neurosurg 1981; 83:105-35.
6. Oosterhuis H. Clinical aspects. In: De Baets M, Oosterhuis H, eds. Myasthenia gravis. Boca Raton: CRC, 1993:13-42.
7. Lindstrom J, & Lennon V, Sevboid M et al. Experimental auto-immune myasthema gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann NY Acad Sci 1976; 274:254-74.
8. Toyka K, Drachman D, Pestronk A et al Myasthenia gravis: passive transfer from man to mouse. Science 1975; 190:397-9.
9. Tzartos S, Hochschwender S, Vasquez P et al. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. J Neuroimmunol 1987; 15:185-94.
10. Biesecker G, Koffler D. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. J Immunol 1988; 140:3406-10.
11. Graus Y, Verschuuren J, Spaans F et al. Age-related resistance to experimental autoimmune myasthenia gravis in rats. J Immunol 1993; 150:4093-103.
12. Price G, Makinodan T. Immunologic deficiencies in senescence. I Characterization of intrinsic deficiencies. J Immunol 1972; 108:403-12.
13. Goidl E, Michelis M, Siskind G et al Effect of age on the induction of autoantibodies. Clin Exp Immunol 1981; 44:24-30.
14. Talor E, Rose N. Hypothesis: the aging paradox and autoimmune disease. Autoimmunity 1991; 8:245-9.
15. Weigle W, Chu E. Age-related changes in the immune system and associated autoimmunity. Aging: Immunology and infectious disease 1994; 5:133-46.
16. Segal R, Globerson A, Zinger H et al. The influence of aging on the induction and manifestations of experimental systemic lupus erythematosus. J Clin Immunol 1992; 12:314-46.
17. Romball C, Weigle W. The effect of aging on the induction of experimental autoimmune thyroiditis. J Immunol 1987; 139:1490-5.
18. Roubinian J, Papoian R, Talal N. Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest 1977; 59:1066-70.
19. 1 females of different age. Arthritis Rheum 1980; 23:41-47.
20. Lindstrom J, Anholt R, Einarson B et al. Purification of acetylcholine receptors, reconstitution into lipid vesicles and study of agonist-induced cation channel regulation. J Biol Chem 1980; 255:8340-50.
21. Lennon V, Lindstrom J, Seybold M. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J Exp Med 1975; 141:1365-75.
22. Verschuuren J, Spaans F, De Baets M. Single-fiber electromyography in experimental autoimmune myasthenia gravis, Muscle Nerve 1990; 13:485-92.
23. Verschuuren J, Graus Y, Theunissen R et al. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis. J Neuroimmunol 1992; 36:117-25.
24. Tzartos S, Remoundos M. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor α-subunit. Dissecting a potentially myasthenogenic epitope. Eur J Biochem 1992; 207:915-22.
25. Sophianos D, Tzartos S. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera, J Autoimmun 1989; 2:1-13.
26. Luther M, Schoepfer R. Whiting P et al. A muscle acetylcholine receptor is expressed in the human cerebellar medullohlastoma cell line TE671. J Neurosci 1989; 9:1082-96.
27. Bionda A, De Baets M, Tzartos S et al. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis. Clin Exp Immunol 1984; 57:41-50.
28. Conti-Tronconi M, McLane K, Ruftery M et al. The nicotinic acelycholine receptor: structure and autoimmune pathology. Crit Rev Biochem Mol Biol 1994; 29:69-123.
29. Witzemann V, Stein E, Barg B et al. Primary structure and functional expression of the α-, β-, γ-, δ- and ε-subunits of the acetylcholine receptor from rat muscle. Eur J Biochem 1990; 194:437-48.
30. Arreaza E, Gibbons J. Siskind G et al. Lower antibody response to tetanus toxoid associated with higher auto-anti-idiotypic antibody in old compared with young humans. Clin Exp Immunol 1993; 92:169-73.
31. Price G, Makinodan T. Immunologic deficiencies in senescence. II Characterization of extrinsic deficiencies. J Immunol 1972; 108:413-7.
32. Zoda T, Yeh T, Krolick K. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats. J Immunol 1991; 146:663-70.
33. Bazin H. Rat hybridomas and rat monoclonal antibodies, 1st edn. Boca Raton: CRC Press, 1990.
34. Gasque P, Morgan B, Legoedec J et al. Human skeletal myoblasts spontaneously activate allogeneic complement but are resistant to killing. J Immunol 1996; 156:3402-11.
35. Lennon V, Seybold M, Lindstrom J et al. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med 1978; 147:973-83.
36. Christadoss P. C5 gene influences the development of murine myasthenia gravis. J Immunol 1988; 140:2589-92.
37. Tzartos S, Sophianos D. Efthimiadis A. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. A Fab monoclonal antibody protects against antigenic modulation by human sera. J Immunol 1985; 134:2343-9.
38. Tzartos S, Barkas T, Cung M et al. The main immunogenic region of the acetylcholine receptor. Structure and role in myasthenia gravis. Autoimmunity 1991; 8:259-70.
39. Graus Y, van Breda Vriesman P, De Baets M. Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis. Clin Exp Immunol 1993; 92:506-13.
40. Lefvert A, Cuenoud S, Fulpius B. Binding properties and subclass distribution of anti-acetylcholine receptor antibodies in myasthenia gravis. J Neuroimmunol 1981; 1:125-35.
41. Drachman D, Adams R, Josifek L et al. Functional activities of autoantibodies to acelylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982; 307:769-75.
42. Plomp J, Van Kempen G, De Baets M et al. Acetylcholine release in myasthenia gravis: regulation at single endplate level. Ann Neurol 1995; 37:627-36.
43. Smith D, Williams K, Emmerling M. Changes in acetylcholine receptor distribution and binding properties at the neuromuscular junction during aging, Int J Devl Neuroscience 1990; 8:629-42.
44. Wokke J, Jennekens F, van den Oord C et al. Morphological changes in the human end plate with age. J Neurol Sci 1990; 95:291-310.
45. Courtney J, Steinbach J. Age changes in neuromuscular junction morphology and ucetylcholine receptor distribution on rat skeletal muscle fibres. J Physiol 1981; 320:435-47.
46. Oda K. Age changes of motor innervation and acetylcholine receptor distribution on human skeletal muscle fibers. J Neurol Sci 1984; 66:327-38.
47. Verheul H, Stimson W, Den Hollander F et al. The effects of nandrolon, testoterone and their decanoate esters on murine lupus. Clin Exp Immunol 1981; 44:11-17.
48. 1 mice. J Exp Med 1978; 147:1568-83.
49. Schuurs A, Dietrich H, Gruber J et al. Effects of sex steroid analogs on spontaneous autoimmune thyroiditis in obese strain chickens, Int Arch Allergy Immunol 1992; 97:337-44.
50. De Baets M, Verschuuren J, Daha M et al. Effects of the rate of acetycholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis. Immunol Res 1988; 7:200-11.